Bostwick Laboratories Revenue and Competitors

Glen Allen, VA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Bostwick Laboratories's estimated annual revenue is currently $63.6M per year.(i)
  • Bostwick Laboratories's estimated revenue per employee is $297,000

Employee Data

  • Bostwick Laboratories has 214 Employees.(i)
  • Bostwick Laboratories grew their employee count by -2% last year.

Bostwick Laboratories's People

NameTitleEmail/Phone
1
VP Sales and MarketingReveal Email/Phone
2
VP UrologyReveal Email/Phone
3
Chief Medical OfficerReveal Email/Phone
4
Registration ManagerReveal Email/Phone
5
Pathology Territory Business ManagerReveal Email/Phone
6
SalesReveal Email/Phone
7
Financial AnalystReveal Email/Phone
8
Pathology Sales RepresentativeReveal Email/Phone
9
SupervisorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46M15541%N/AN/A
#2
$3862.4M10218N/AN/AN/A
#3
$18M7410%N/AN/A
#4
$18.2M7539%N/AN/A
#5
$27.8M1035%N/AN/A
#6
$9.3M4343%N/AN/A
#7
$23M85-13%N/AN/A
#8
$16.3M6726%N/AN/A
#9
$4.3M23-36%N/AN/A
#10
$37M137-5%N/AN/A
Add Company

What Is Bostwick Laboratories?

Bostwick Laboratories, Inc. a specialized anatomic pathology laboratory focused on the diagnosis of cancer. The Company delivers diagnostic reports providing physicians with the ability to make treatment decisions with their patients. The Company has five laboratories located in Virginia, Arizona, New York, Florida, and London, England. During the year ended December 31, 2007, it analyzed approximately 291,000 accessions or cases. Bostwick Laboratories, Inc. operates in the non-hospital, or outpatient, segment of the United States anatomic pathology market. Within that market, it serves, urologic pathology, including prostate cancer biopsies, and gynecologic pathology, including cervical cancer screenings. The Company operates four divisions that provide anatomic pathology services in urology, gynecology, gastroenterology and nephrology.

keywords:N/A

N/A

Total Funding

214

Number of Employees

$63.6M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Bostwick Laboratories News

2011-10-25 - Bostwick Laboratories Receives Majority Investment from Metalmark Capital

Bostwick Laboratories, Inc., a provider of urologic anatomic pathology laboratory services in the United States, has received a majority investment of undisclosed amount from New York-based private equity firm Metalmark Capital. Following the investment, Founder and CEO, Dr. David G. Bostwick, ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.6M219-11%$1.6B
#2
$67.4M227-17%N/A
#3
$38M23823%N/A
#4
$55.4M240-8%N/A
#5
$35M270N/AN/A